Ranu Baral i wsp. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19A Systematic Review and Meta-analysis.
JAMA Netw Open. 2021;4(3):e213594
Meaning The study’s findings suggest that ACEIs and ARBs may be associated with protective benefits for patients with COVID-19 and that patients may continue receiving ACEIs and ARBs for the treatment of any condition without an increased risk of worse outcomes unless specifically advised to avoid them by treating clinicians.
JAMA Network Open, 31 marca 2021